Clinical Trial Update: Hyperkalemia Quality Improvement Program (HK-QIP) Study [NA]

View source ↗

Summary

AstraZeneca-sponsored Hyperkalemia Quality Improvement Program study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Snippet

Sponsor: AstraZeneca | Conditions: Hyperkalemia | NA | Status: RECRUITING